Children's Health Defense
As early as January 2022, National Institutes of Health (NIH) researchers were aware of at least 850 peer-reviewed case reports and/or research articles about COVID-19 vaccine reactions, according to emails obtained by Children’s Health Defense (CHD).
In one email (name and agency redacted), NIH researchers were told the federal government was “saddled” with the “mess” of dealing with those injured by the COVID-19 vaccines, due to the liability shield enjoyed by vaccine manufacturers.
The emails, part of a 309-page batch of documents released to CHD on June 21, originated from a U.S. Food and Drug Administration (FDA) request to NIH researchers for input on a report highlighting several injuries common among people who received the vaccines.
CHD requested the documents via a Freedom of Information Act (FOIA) request to the NIH in November 2022. When the NIH hadn’t responded by April 2023, CHD sued the agency.
In an October 2023 settlement, the NIH agreed to produce up to 7,500 pages of documents at a rate of 300 pages per month.
The batch of documents released in June — which include emails to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research — revealed that by fall 2021, key NIH researchers were aware of scientific studies on serious adverse events, including persistent neurological symptoms, following COVID-19 vaccines.
As with prior releases of the NIH documents, June’s tranche also included several emails from vaccine-injured individuals to NIH researchers, seeking help for their symptoms — with one person asking, “Why aren’t you studying vaccine injuries?”
‘Tinnitus … was a freight train in my head for the first four months’
On Jan. 10, 2022, NIH researcher Dr. Avindra Nath was forwarded an email from someone whose name is redacted, with the subject line: “Followup [sic] Jan 4th Meeting” (pages 281-289).
The original email, dated Jan. 9, 2022, was sent to FDA officials including Marks and Dr. Janet Woodcock, principal deputy commissioner of food and drugs, who apparently participated in a meeting on this topic on Jan. 4, 2022.
The Jan. 9, 2022 email included a list of “persistent symptoms following the Covid vaccines” and the names of researchers who were studying these conditions, which included dysautonomia, neuropathy, tinnitus, multisystem inflammatory syndrome (MIS), myocarditis, blood clots and parasthesias.
The email was accompanied by a spreadsheet listing approximately 850 “peer-reviewed case reports/research articles about Covid vaccine reactions.”
Regarding dysautonomia — a nervous system disorder that disrupts automatic bodily functions — the email stated that the condition is “grossly under diagnosed” and “is not diagnosed in ERs or ICUs” but in “autonomic specialty labs.”
The email noted that such labs are less likely than hospitals to file reports with the Vaccine Adverse Event Reporting System (VAERS) and added that there “likely are issues with identifying this syndrome if only looking through VAERS or similarly reported databases.”
As a result, the email suggested “it would be reasonable to approach autonomic specialists / long covid specialists about their observations.”
A 2011 Harvard study found that less than 1% of all adverse events are reported to VAERS.
The Jan. 9, 2022, email also noted unusual trends regarding diagnoses of neuropathy — a set of neurological symptoms that includes numbness and tingling in the hands or feet, and a burning, stabbing or shooting pain in affected areas.
According to the email, “Historically, neuropathy presents in the predominantly male population aged 59+. However as discussed previous [sic], neuropathy in our case is predominantly female, aged 29-40.”
As with dysautonomia, the email noted that neuropathy is “likely to be inadequately reported through the VAERS and BEST [Biologics Effectiveness and Safety] systems because of the circumstances previously mentioned for dysautonomia.”
The Jan. 9, 2022 email also acknowledged that tinnitus was a common post-vaccination injury, noting, “Our findings are that this is not just J&J [the Johnson & Johnson, or Janssen, COVID-19 vaccine] … not by a long shot.”
According to the email, “This symptom is more proportionate to the general neuro symptoms by brand as previously reported in our patient led survey of 500 participants.”
The email’s author also noted that, “in my case yes, I have tinnitus now and it was a freight train in my head for the first four months.”…
READ FULL ARTICLE HERE... (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Be First to Comment